Over the last 15 years, research into the gut microbiome — the ecosystem of microorganisms that reside in the gut — has garnered increasing attention. With the emergence of supplements and food products that claim to improve your gut health, the term “gut microbiome” has become a familiar idea to the general public.
A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current inflammatory bowel disease treatments.
Dr. Paula Littlejohn received her PhD in microbiology and immunology from the University of British Columbia (UBC) under the supervision of Dr. Brett Finlay. She is currently a postdoctoral research fellow co-supervised by Dr. Michael Kobor and Dr. Bruce Vallance at BC Children’s Hospital Research Institute (BCCHR).
For Media
Every day, our researchers are working towards breakthroughs to transform the lives of kids in British Columbia and around the world. Learn about the latest innovations and advancements in child health.